Inflammasome assembly in neurodegenerative diseases.

AIM2 Alzheimer’s disease NLRC4 NLRP1 NLRP3 Parkinson’s disease amyotrophic lateral sclerosis frontotemporal dementia multiple sclerosis

Journal

Trends in neurosciences
ISSN: 1878-108X
Titre abrégé: Trends Neurosci
Pays: England
ID NLM: 7808616

Informations de publication

Date de publication:
10 2023
Historique:
received: 30 04 2023
revised: 26 06 2023
accepted: 31 07 2023
pmc-release: 01 10 2024
medline: 22 9 2023
pubmed: 27 8 2023
entrez: 26 8 2023
Statut: ppublish

Résumé

Neurodegenerative disorders are characterized by the progressive dysfunction and death of selectively vulnerable neuronal populations, often associated with the accumulation of aggregated host proteins. Sustained brain inflammation and hyperactivation of inflammasome complexes have been increasingly demonstrated to contribute to neurodegenerative disease progression. Here, we review molecular mechanisms leading to inflammasome assembly in neurodegeneration. We focus primarily on four degenerative brain disorders in which inflammasome hyperactivation has been well documented: Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and the spectrum of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). We discuss shared and divergent principles of inflammasome assembly across these disorders, and underscore the differences between neurodegeneration-associated inflammasome activation pathways and their peripheral-immune counterparts. We examine how aberrant assembly of inflammasome complexes may amplify pathology in neurodegeneration, including misfolded protein aggregation, and highlight prospects for neurotherapeutic interventions based on targeting inflammasome pathways.

Identifiants

pubmed: 37633753
pii: S0166-2236(23)00174-1
doi: 10.1016/j.tins.2023.07.009
pmc: PMC10530301
mid: NIHMS1922690
pii:
doi:

Substances chimiques

Inflammasomes 0

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

814-831

Subventions

Organisme : NIA NIH HHS
ID : R00 AG066862
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Cell. 2010 Mar 19;140(6):918-34
pubmed: 20303880
Neuron. 2023 Apr 19;111(8):1222-1240.e9
pubmed: 36917977
Glia. 2020 Feb;68(2):407-421
pubmed: 31596526
Neurology. 2014 Mar 25;82(12):1045-50
pubmed: 24598707
Autophagy. 2014 Oct 1;10(10):1761-75
pubmed: 25126727
Nat Neurosci. 2019 Oct;22(10):1635-1648
pubmed: 31551592
PLoS One. 2015 Oct 07;10(10):e0139684
pubmed: 26444282
J Neuroinflammation. 2020 Jul 17;17(1):213
pubmed: 32680528
J Neurol. 2002 Oct;249 Suppl 3:III/1-5
pubmed: 12528692
NPJ Parkinsons Dis. 2017 Oct 17;3:30
pubmed: 29057315
Brain Behav Immun. 2017 Mar;61:306-316
pubmed: 28003153
Nat Genet. 2013 Dec;45(12):1452-8
pubmed: 24162737
Cold Spring Harb Perspect Biol. 2017 Jul 5;9(7):
pubmed: 28062563
Nat Commun. 2013;4:1562
pubmed: 23463005
Aging Cell. 2023 Jun;22(6):e13834
pubmed: 37029500
J Neurosci. 2013 Mar 13;33(11):5053-64
pubmed: 23486975
Brain. 2008 Jul;131(Pt 7):1880-94
pubmed: 18504291
J Clin Invest. 2007 Jun;117(6):1595-604
pubmed: 17549256
Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):E1926-35
pubmed: 25825709
Sci Rep. 2021 Jun 25;11(1):13316
pubmed: 34172778
Exp Neurobiol. 2015 Jun;24(2):103-16
pubmed: 26113789
Neuron. 2014 Mar 5;81(5):1001-1008
pubmed: 24508385
Curr Neurol Neurosci Rep. 2006 Jan;6(1):37-46
pubmed: 16469270
Methods Find Exp Clin Pharmacol. 1994 Mar;16(2):141-51
pubmed: 8007743
Neuron. 2014 Dec 17;84(6):1213-25
pubmed: 25521377
Cell Rep. 2021 Sep 21;36(12):109720
pubmed: 34551296
Neurosci Lett. 1996 Jun 14;211(1):13-6
pubmed: 8809836
Mol Neurobiol. 2017 Aug;54(6):4486-4495
pubmed: 27356916
J Neural Transm Suppl. 2000;(58):143-51
pubmed: 11128604
Neuron. 2018 Mar 7;97(5):1023-1031.e7
pubmed: 29518356
Cell Death Dis. 2014 Aug 21;5:e1382
pubmed: 25144717
Cell. 2019 Jul 25;178(3):536-551.e14
pubmed: 31257024
Cell Rep. 2022 Sep 20;40(12):111401
pubmed: 36130498
Pharmacol Rev. 2006 Sep;58(3):591-620
pubmed: 16968951
Nature. 2009 Mar 26;458(7237):509-13
pubmed: 19158676
Nature. 2019 Nov;575(7784):669-673
pubmed: 31748742
Mov Disord. 2016 Mar;31(3):366-76
pubmed: 26853432
Arthritis Rheum. 2002 Sep;46(9):2445-52
pubmed: 12355493
J Immunol. 2017 Mar 1;198(5):2156-2164
pubmed: 28130493
EMBO Mol Med. 2017 Jan;9(1):61-77
pubmed: 27861127
Front Neurosci. 2020 Feb 05;14:42
pubmed: 32116499
JCI Insight. 2023 Feb 8;8(3):
pubmed: 36602874
EMBO J. 2019 Sep 2;38(17):e101064
pubmed: 31359456
Acta Neuropathol. 2019 Apr;137(4):599-617
pubmed: 30721409
N Engl J Med. 1998 Jan 29;338(5):278-85
pubmed: 9445407
Cell Death Differ. 2015 Oct;22(10):1676-86
pubmed: 25744023
Nature. 2013 Jan 31;493(7434):674-8
pubmed: 23254930
Cell. 1993 Nov 19;75(4):653-60
pubmed: 8242741
EMBO J. 2019 Feb 15;38(4):
pubmed: 30617086
J Neurosci. 2020 Feb 26;40(9):1956-1974
pubmed: 31980586
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13046-50
pubmed: 20616033
Mol Neurodegener. 2016 Mar 03;11:23
pubmed: 26939933
Sci Adv. 2020 Aug 14;6(33):eabb9036
pubmed: 32851186
J Immunol. 2010 Jul 15;185(2):974-81
pubmed: 20574004
Nat Commun. 2018 Sep 25;9(1):3916
pubmed: 30254377
Immunity. 2017 Sep 19;47(3):566-581.e9
pubmed: 28930663
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
J Immunol. 1999 Sep 1;163(5):2403-9
pubmed: 10452974
Neurobiol Aging. 1996 Sep-Oct;17(5):761-6
pubmed: 8892349
EMBO Mol Med. 2021 Apr 9;13(4):e13076
pubmed: 33646633
Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):9002-9007
pubmed: 30127003
Mol Neurodegener. 2017 May 26;12(1):43
pubmed: 28549481
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18754-9
pubmed: 18000063
Nat Immunol. 2008 Aug;9(8):857-65
pubmed: 18604209
Lancet. 2015 Oct 24;386(10004):1672-82
pubmed: 26595641
Neuron. 2011 Oct 20;72(2):245-56
pubmed: 21944778
Nature. 2017 Dec 20;552(7685):355-361
pubmed: 29293211
J Parkinsons Dis. 2015;5(1):1-19
pubmed: 25588354
Nature. 2004 Jul 8;430(6996):213-8
pubmed: 15190255
Sci Adv. 2020 Dec 4;6(49):
pubmed: 33277246
J Neurochem. 2020 Dec;155(6):650-661
pubmed: 31872431
J Exp Med. 2007 Dec 24;204(13):3235-45
pubmed: 18070936
Eur J Neurosci. 2002 Mar;15(6):991-8
pubmed: 11918659
Nat Rev Immunol. 2022 Nov;22(11):657-673
pubmed: 35246670
Neurobiol Aging. 1996 Sep-Oct;17(5):673-80
pubmed: 8892339
Elife. 2022 Oct 31;11:
pubmed: 36314770
Acta Neurol Scand Suppl. 2008;188:72-6
pubmed: 18439226
J Biol Chem. 2002 Jun 14;277(24):21119-22
pubmed: 11967258
J Immunol. 2003 Dec 15;171(12):6329-33
pubmed: 14662828
Nat Commun. 2015 Feb 18;6:6282
pubmed: 25693118
Cell Rep. 2018 Nov 27;25(9):2339-2353.e4
pubmed: 30485804
Neuroimmunomodulation. 2017;24(1):29-39
pubmed: 28618410
Nature. 2020 Apr;580(7805):647-652
pubmed: 32350463
Nat Immunol. 2014 Aug;15(8):727-37
pubmed: 24952505
Cell. 2015 Jan 15;160(1-2):62-73
pubmed: 25594175
Glia. 2022 Dec;70(12):2409-2425
pubmed: 35959803
J Neurosci. 2010 Nov 24;30(47):15811-20
pubmed: 21106820
JCI Insight. 2022 Apr 22;7(8):
pubmed: 35451371
Immunity. 2013 Jan 24;38(1):27-40
pubmed: 23260196
Nat Genet. 2001 Nov;29(3):301-5
pubmed: 11687797
Tohoku J Exp Med. 1994 Nov;174(3):295-303
pubmed: 7539162
Hum Mol Genet. 2009 Sep 1;18(17):3217-26
pubmed: 19483195
Nature. 2009 Mar 26;458(7237):514-8
pubmed: 19158675
Nat Rev Neurosci. 2001 Nov;2(11):806-19
pubmed: 11715057
Neurology. 1988 Aug;38(8):1285-91
pubmed: 3399080
J Neuroinflammation. 2006 Mar 16;3:5
pubmed: 16542445
Nature. 2021 Mar;591(7849):300-305
pubmed: 33505023
Cells. 2022 Oct 05;11(19):
pubmed: 36231090
Neurobiol Learn Mem. 2002 Sep;78(2):379-89
pubmed: 12431424
Am J Pathol. 2001 Jan;158(1):63-73
pubmed: 11141480
Nat Rev Neurosci. 2019 Jan;20(1):19-33
pubmed: 30467385
Transl Neurodegener. 2020 Nov 26;9(1):42
pubmed: 33239064
J Neuroinflammation. 2005 Jun 20;2:15
pubmed: 15967035
Proc Natl Acad Sci U S A. 1989 Oct;86(19):7611-5
pubmed: 2529544
J Exp Med. 2017 Jun 5;214(6):1725-1736
pubmed: 28465465
Nature. 1997 Jul 3;388(6637):31
pubmed: 9214497
J Exp Med. 2019 Nov 4;216(11):2562-2581
pubmed: 31467036
Nat Commun. 2018 May 23;9(1):2036
pubmed: 29789522
Cell Microbiol. 2006 Nov;8(11):1812-25
pubmed: 16824040
Nat Immunol. 2014 Aug;15(8):738-48
pubmed: 24952504
Nature. 2015 Feb 19;518(7539):365-9
pubmed: 25693568
Neuron. 2022 Aug 3;110(15):2422-2437.e9
pubmed: 35654037
Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2118819119
pubmed: 35394877
Cytokine Growth Factor Rev. 2017 Oct;37:89-97
pubmed: 28599834
J Immunol. 2003 Dec 1;171(11):6154-63
pubmed: 14634131
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):9593-8
pubmed: 27482103
J Neuroinflammation. 2022 Feb 16;19(1):50
pubmed: 35172843
Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):
pubmed: 34187891
J Exp Med. 2021 May 3;218(5):
pubmed: 33710283
J Parkinsons Dis. 2018;8(s1):S3-S8
pubmed: 30584159
Br J Pharmacol. 2011 Oct;164(4):1079-106
pubmed: 21371012
J Exp Med. 2022 Dec 5;219(12):
pubmed: 36107206
Nat Chem Biol. 2005 Jul;1(2):112-9
pubmed: 16408008
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
Exp Neurol. 2015 Nov;273:24-35
pubmed: 26222336
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7778-83
pubmed: 9636227
Cell Rep. 2023 Feb 28;42(2):112133
pubmed: 36800288
J Clin Invest. 2018 Dec 3;128(12):5399-5412
pubmed: 30372424
Nature. 2016 Jul 7;535(7610):111-6
pubmed: 27281216
J Biol Chem. 2009 Jul 24;284(30):20329-39
pubmed: 19465477
J Neuroinflammation. 2006 Jul 26;3:17
pubmed: 16872492
JAMA. 2021 Feb 23;325(8):765-779
pubmed: 33620411
J Immunol. 2021 Oct 15;207(8):2143-2154
pubmed: 34507948
N Engl J Med. 2000 Sep 28;343(13):938-52
pubmed: 11006371
Inflamm Regen. 2019 Jun 6;39:12
pubmed: 31182982
J Neural Transm (Vienna). 2000;107(3):335-41
pubmed: 10821442
Nat Aging. 2021 Aug;1(8):634-650
pubmed: 34901876
Acta Neuropathol Commun. 2018 Mar 2;6(1):22
pubmed: 29499767
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):9587-92
pubmed: 27482083
Neuron. 2007 Feb 1;53(3):337-51
pubmed: 17270732
Nature. 2011 Jan 13;469(7329):221-5
pubmed: 21124315
Lancet Neurol. 2019 May;18(5):459-480
pubmed: 30879893
Nat Immunol. 2012 Jan 29;13(3):255-63
pubmed: 22286270
EMBO J. 2021 Dec 15;40(24):e108662
pubmed: 34825707
Brain Plast. 2021 Aug 23;7(1):17-32
pubmed: 34631418
Science. 2016 Aug 5;353(6299):603-8
pubmed: 27493188
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10480-5
pubmed: 22699511
Nat Immunol. 2009 Mar;10(3):266-72
pubmed: 19158679
Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8788-E8797
pubmed: 28904096
Cell Rep. 2022 Oct 25;41(4):111532
pubmed: 36288697
NPJ Parkinsons Dis. 2018 Aug 15;4:24
pubmed: 30131971
Sci Signal. 2015 May 12;8(376):ra45
pubmed: 25969543
J Exp Med. 2019 Jun 3;216(6):1411-1430
pubmed: 31036561
Sci Transl Med. 2018 Oct 31;10(465):
pubmed: 30381407
J Exp Med. 2017 May 1;214(5):1351-1370
pubmed: 28404595

Auteurs

Jagjit Singh (J)

Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Maria L Habean (ML)

Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Biomedical Scientist Training Program (Department of Neurosciences), Case Western Reserve University, Cleveland, OH, USA.

Nikhil Panicker (N)

Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44106, USA; Kent State University, Neurosciences, School of Biomedical Sciences, Cleveland, OH, USA. Electronic address: PANICKN@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH